Core Viewpoint - The stock price of Steady Medical reached 40.11 yuan as of August 1, 2025, showing a 0.27% increase from the previous trading day, indicating a positive market response to recent developments [1] Company Overview - Steady Medical focuses on the research, production, and sales of medical consumables, with products including medical dressings and operating room supplies [1] - The company operates in various sectors, including beauty care and cross-border e-commerce [1] Recent Developments - Steady Medical announced the launch of a new type of medical dressing that utilizes innovative material technology, offering improved breathability and comfort [1] - The company claims that this new product will enhance its competitiveness in the medical consumables market [1] Financial Performance - On August 1, the net inflow of main funds was 61.17 thousand yuan, although the overall trend over the past five days showed a net outflow of 1.05 billion yuan [1] - The trading volume for the day was 46,216 hands, with a total transaction amount of 1.86 billion yuan [1]

（原标题：美容护理行业本周跌3.30%，主力资金净流出8.22亿元） 美容护理行业资金流向排名 | 代码 | 简称 | 一周涨跌幅（%） | 一周换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 300896 | 爱美客 | -3.67 | 7.50 | -16152.43 | | 300888 | 稳健医疗 | -5.58 | 23.81 | -9903.50 | | 002094 | 青岛金王 | -3.69 | 34.44 | -8144.37 | | --- | --- | --- | --- | --- | | 603605 | 珀莱雅 | -2.38 | 6.47 | -7231.63 | | 300957 | 贝泰妮 | -3.08 | 4.64 | -6270.02 | | 002511 | 中顺洁柔 | -3.18 | 10.53 | -4998.09 | | 688363 | 华熙生物 | -3.49 | 4.95 | -4676.63 | | 603630 | 拉芳家化 | -6.52 | 16.54 | -4086.99 | ...

Group 1 - The stock price of Steady Medical (300888) closed at 40.11 yuan on August 1, 2025, with a slight increase of 0.28% and a trading volume of 46,200 hands, resulting in a transaction amount of 186 million yuan [1] - The net inflow of main funds was 611,700 yuan, accounting for 0.33% of the total transaction amount, while retail investors experienced a net outflow of 2,040,820 yuan, representing 11.0% of the total transaction amount [1] - Over the past five days, the stock has seen fluctuations in fund flows, with significant net outflows from main funds on July 31, 2025, amounting to 27.43 million yuan [1] Group 2 - Steady Medical's total market value is 23.357 billion yuan, ranking 4th in the beauty and personal care industry, which has an average market value of 10.844 billion yuan [2] - The company reported a net profit of 249 million yuan for Q1 2025, reflecting a year-on-year increase of 36.26%, with a gross profit margin of 48.46% [2] - The company's return on equity (ROE) stands at 2.13%, which is higher than the industry average of 1.91% [2] Group 3 - In the last 90 days, 22 institutions have rated the stock, with 18 buy ratings and 4 hold ratings, and the average target price set by institutions is 58.04 yuan [3]

Market Overview - The personal care products sector increased by 0.68% on August 1, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 3559.95, down 0.37%, while the Shenzhen Component Index closed at 10991.32, down 0.17% [1] Stock Performance - Beijia (603059) closed at 33.78, up 10.00% with a trading volume of 22,200 lots and a transaction value exceeding 74.98 million yuan [1] - Runben Co. (603193) closed at 33.00, up 3.48% with a trading volume of 126,400 lots and a transaction value of 414 million yuan [1] - Yanjing Co. (300658) closed at 6.96, up 2.65% with a trading volume of 240,700 lots and a transaction value of 167 million yuan [1] - Other notable stocks include Nobon Co. (603238) at 17.51 (+2.46%), Ziya Co. (003006) at 25.95 (+1.57%), and Liangmian Needle (600249) at 5.81 (+1.22%) [1] Capital Flow - The personal care products sector saw a net inflow of 8.97 million yuan from institutional investors, while retail investors contributed a net inflow of 18.89 million yuan [2] - However, there was a net outflow of 27.85 million yuan from speculative funds [2] Detailed Capital Flow Analysis - Runben Co. had a net inflow of 60.92 million yuan from institutional investors, but a net outflow of 28.99 million yuan from speculative funds [3] - Beijia experienced a net inflow of 12.06 million yuan from institutional investors, with a net outflow of 10.82 million yuan from speculative funds [3] - Nobon Co. had a net inflow of 1.84 million yuan from retail investors despite a net outflow from institutional and speculative funds [3] - Liangmian Needle saw a net inflow of 0.80 million yuan from retail investors, while experiencing a net outflow from institutional and speculative funds [3]

Core Viewpoint - The stock of Steady Medical (300888) has experienced a decline, with significant net outflows from major funds, indicating potential concerns among institutional investors [1][2]. Financial Performance - As of July 31, 2025, Steady Medical's stock closed at 40.00 yuan, down 2.32%, with a trading volume of 67,000 hands and a transaction amount of 270 million yuan [1]. - The company reported a main revenue of 2.605 billion yuan for Q1 2025, a year-on-year increase of 36.47%, and a net profit attributable to shareholders of 249 million yuan, also up 36.26% year-on-year [3]. - The company's gross profit margin stands at 48.46%, which is higher than the industry average of 42.27% [3]. Market Position - Steady Medical has a total market value of 23.293 billion yuan, ranking 4th in the beauty and personal care industry, with a net asset value of 12.146 billion yuan, ranking 1st [3]. - The company's price-to-earnings ratio (P/E) is 23.43, which is lower than the industry average of 39.83, indicating a potentially undervalued stock [3]. Fund Flow Analysis - On July 31, 2025, the net outflow of major funds was 27.4298 million yuan, accounting for 10.15% of the total transaction amount, while retail investors saw a net inflow of 7.5146 million yuan, representing 2.78% of the total [1][2]. - Over the past five days, the stock has seen fluctuating fund flows, with significant net outflows from major funds on multiple days [2]. Institutional Ratings - In the last 90 days, 23 institutions have rated the stock, with 19 buy ratings and 4 hold ratings, indicating a generally positive outlook among analysts [4]. - The average target price set by institutions over the past 90 days is 58.04 yuan, suggesting potential upside from the current trading price [4].

通过天眼查大数据分析，稳健医疗用品股份有限公司共对外投资了22家企业，参与招投标项目561次， 知识产权方面有商标信息449条，专利信息598条，此外企业还拥有行政许可239个。 来源：金融界 稳健医疗最新一期业绩显示，截至2025一季报，公司营业总收入26.05亿元、同比增长36.47%，归属净 利润2.49亿元，同比增长36.26%，扣非净利润2.34亿元，同比增长62.46%，流动比率1.695、速动比率 1.252、资产负债率31.72%。 天眼查商业履历信息显示，稳健医疗用品股份有限公司，成立于2000年，位于深圳市，是一家以从事医 药制造业为主的企业。企业注册资本58232.9808万人民币。公司法定代表人为李建全。 金融界消息 截至2025年7月31日收盘，稳健医疗（300888）报收于40.0元，下跌2.32%，换手率3.82%， 成交量6.70万手，成交金额2.70亿元。 资金流向方面，今日主力资金净流出2742.98万元，占比成交额10.15%。其中，超大单净流出834.79万 元、占成交额3.09%，大单净流出1908.19万元、占成交额7.06%，中单净流出流入1991.51万元、占成 ...

Core Insights - The total salary scale for CFOs in A-share listed companies reached 4.27 billion yuan in 2024, with an average annual salary of 814,800 yuan [1] - The highest annual salary for a CFO in the beauty and skincare industry was 2.933 million yuan, paid to Wang Li of Proya [2][3] - There are nearly 12 listed companies in the beauty and skincare sector where CFO salaries exceed 1 million yuan [2] Salary Overview - The average annual salary for CFOs in the beauty and skincare industry is 770,000 yuan [1] - The highest salaries among CFOs in this sector include: - Proya: 2.933 million yuan - Betaini: 2.82 million yuan - Aimeike: 2.335 million yuan - Baiya: 2.048 million yuan - Sturdy Medical: 2.015 million yuan [2][3] Company Performance - Qing Song Co.'s CFO, Wang Yucai, has seen the company's revenue decline for four consecutive years, with net profit once falling into the red [1][4] - Sturdy Medical's accounts receivable growth rate outpaced revenue growth, leading to a rising accounts receivable to revenue ratio and declining gross profit margin [3] - Aimeike experienced a significant slowdown in revenue and net profit growth, with multiple profitability indicators declining [3][4] - Betaini reported increased revenue but decreased profitability, with several operational capability indicators also declining [4] Age Demographics of CFOs - The youngest CFOs in the industry are Wang Yucai from Qing Song Co. and Zou Fei from Shui Yang Co., both aged 35 [4] - The oldest CFO is Dong Ye from Zhongshun Jierou, aged 61 [4]

Core Insights - The total salary scale for CFOs in A-share listed companies reached 4.27 billion yuan in 2024, with an average annual salary of 814,800 yuan [1] - The highest annual salary for a CFO in the beauty and skincare industry was 2.93 million yuan, paid to Wang Li of Proya [2][3] - The beauty and skincare industry saw nearly 12 listed companies with CFO salaries exceeding 1 million yuan, indicating a competitive compensation landscape [2] Salary Breakdown - The CFOs of the following companies received salaries exceeding 2 million yuan: - Fang Xiuyuan from Sturdy Medical: 2.015 million yuan - Zhang Li from Baiya: 2.048 million yuan - Zhang Renzhao from Aimeike: 2.335 million yuan - Wang Long from Betaini: 2.82 million yuan - Wang Li from Proya: 2.933 million yuan [2][3] Industry Performance Indicators - Sturdy Medical reported a higher growth rate in accounts receivable compared to revenue, with a continuous increase in the accounts receivable to revenue ratio, alongside declining sales gross margin and inventory turnover rate [3][4] - Aimeike experienced a significant slowdown in revenue and net profit growth, with multiple profitability indicators showing a decline, including sales gross margin and return on equity [3][4] - Betaini also faced a decline in multiple profitability indicators, including sales gross margin and return on assets, along with deteriorating operational capacity metrics [4] Age Demographics of CFOs - The youngest CFOs in the industry are Zou Fei from Shuiyang and Wang Yucong from Qingsong, both aged 35, while the oldest is Dong Ye from Zhongshun Jierou, aged 61 [4] - Wang Yucong has been the CFO of Qingsong since May 2018, during which the company has seen a continuous decline in revenue over four years and a period of net profit loss [4]

证券之星消息，7月31日个护用品板块较上一交易日下跌1.99%，延江股份领跌。当日上证指数报收于 3573.21，下跌1.18%。深证成指报收于11009.77，下跌1.73%。个护用品板块个股涨跌见下表： 从资金流向上来看，当日个护用品板块主力资金净流出1.63亿元，游资资金净流出4671.12万元，散户资 金净流入2.1亿元。个护用品板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603059 | 倍加洁 | 2786.97万 | 9.56% | -2061.97万 | -7.07% | -725.00万 | -2.49% | | 001328 | 登康口腔 | 783.69万 | 6.75% | -633.61万 | -5.46% | -150.08万 | -1.29% | | 003006 自亚股份 | | 85.10万 | 0.53% | -742.19万 | -4.66% | ...

专题：专题|2024年度A股CFO数据报告：美的集团钟铮年薪946万，比亚迪周亚琳896万 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 作为上市公司核心管理层关键成员，财务总监CFO的地位与作用至关重要。新浪财经《2024年度A股 CFO数据报告》显示，2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元，平均年薪为 81.48万元。 随着年报披露收官，美容护肤行业上市公司财务总监薪酬面纱也被揭开。据数据统计，美容护肤行业上 市公司年薪为77万元，其中为财务总监支付的最高年度薪酬是珀莱雅，为财务总监王莉支付年薪293.3 万元；为CFO支付的最低年度薪酬是两面针，为原财务总监王为民支付年薪34.26万元。 美容护肤行业财务总监薪酬有近12家上市公司的财务薪酬超百万，分别为青松股份、锦波生物、登康口 腔、力合科创、华熙生物、中顺洁柔、稳健医疗、百亚股份、爱美客、华熙生物、贝泰妮、珀莱雅，这 些上市公司分别给财务总监支付年薪115万元、115.7万元、125.78万元、132.08万元、158.77万元、 168.41万元、201.5万元、204.78万元、233.5 ...